$93K for cancer drug raises new ethics question

By Marilynn Marchione

Associated Press

Published: Monday, Sept. 27 2010 1:12 a.m. MDT

"I've not had any patient ask for it," she said. "They ask about it. Based on the information, they think the cost is tremendous, and they think the benefit is very small."

Logothetis, at M.D. Anderson, said Provenge and other experimental cancer vaccines in development need "a national investment" to sort out their potential, starting with Medicare coverage.

Many companies and agencies offer financial help for people who cannot afford cancer treatment.

Financial help

Genentech: www.GenentechAccessSolutions.com

Novartis: www.patientassistancenow.com

Patient Advocate Foundation, 800-532-5274 www.patientadvocate.org

CancerCare, 866-552-6729 www.cancercarecopay.org

Chronic Disease Fund, 877-968-7233 www.cdfund.org

Healthwell Foundation, 800-675-8416 www.healthwellfoundation.org

Leukemia & Lymphoma Society, 877-557-2672 www.LLS.org/copay

National Organization for Rare Disorders 800-999-6673 www.rarediseases.org

Patient Access Network Foundation, 866-316-7263 www.panfoundation.org

Patient Advocate Foundation, 866-512-3861 www.copays.org

Patient Services Inc., 800-366-7741 www.patientservicesinc.org

Get The Deseret News Everywhere

Subscribe

Mobile

RSS